Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
ERCC1 overexpression
i
Other names:
ERCC1, RAD10, Excision repair cross-complementation group 1
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2067
Related biomarkers:
Expression
Mutation
CNA
‹
ERCC1 negative (2)
ERCC1 underexpression (2)
ERCC1 expression (1)
ERCC1 negative (2)
ERCC1 underexpression (2)
ERCC1 expression (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
ERCC1 overexpression
Colorectal Cancer
ERCC1 overexpression
Colorectal Cancer
oxaliplatin
Resistant: C3 – Early Trials
oxaliplatin
Resistant
:
C3
oxaliplatin
Resistant: C3 – Early Trials
oxaliplatin
Resistant
:
C3
ERCC1 overexpression
Sarcoma
ERCC1 overexpression
Sarcoma
doxorubicin hydrochloride + trabectedin
Sensitive: C3 – Early Trials
doxorubicin hydrochloride + trabectedin
Sensitive
:
C3
doxorubicin hydrochloride + trabectedin
Sensitive: C3 – Early Trials
doxorubicin hydrochloride + trabectedin
Sensitive
:
C3
ERCC1 overexpression
Soft Tissue Sarcoma
ERCC1 overexpression
Soft Tissue Sarcoma
trabectedin
Sensitive: C3 – Early Trials
trabectedin
Sensitive
:
C3
trabectedin
Sensitive: C3 – Early Trials
trabectedin
Sensitive
:
C3
ERCC1 overexpression
HER2 Positive Breast Cancer
ERCC1 overexpression
HER2 Positive Breast Cancer
trastuzumab
Resistant: C3 – Early Trials
trastuzumab
Resistant
:
C3
trastuzumab
Resistant: C3 – Early Trials
trastuzumab
Resistant
:
C3
ERCC1 overexpression
Squamous Cell Carcinoma of Head and Neck
ERCC1 overexpression
Squamous Cell Carcinoma of Head and Neck
cisplatin + 5-fluorouracil
Sensitive: C3 – Early Trials
cisplatin + 5-fluorouracil
Sensitive
:
C3
cisplatin + 5-fluorouracil
Sensitive: C3 – Early Trials
cisplatin + 5-fluorouracil
Sensitive
:
C3
ERCC1 overexpression
Solid Tumor
ERCC1 overexpression
Solid Tumor
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
ERCC1 overexpression
Small Cell Lung Cancer
ERCC1 overexpression
Small Cell Lung Cancer
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
cisplatin
Sensitive: C3 – Early Trials
cisplatin
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login